Completed PHASE4 INTERVENTIONAL 2-arm NCT01345604

Intraoperative Posterior Cruciate Ligament (Transcruciate) Injection After Total Knee Arthroplasty (TKA)

Reducing Posterior Knee Pain Following Total Knee Arthroplasty Using an Intraoperative Posterior Cruciate Ligament (Transcruciate) Injection

Sponsor: Saskatoon Health Region

Conditions Arthroplasty, Replacement, Knee

Interventions transcruciate injection of 20 cc of 0.5% Ropivacaine transcruciate injection of 20cc of normal saline

Updated 5 times since 2017 Last updated: Nov 10, 2016 Started: May 31, 2011 Primary completion: May 31, 2013 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01345604, this PHASE4 trial focuses on Arthroplasty, Replacement, Knee and remains completed. Sponsored by Saskatoon Health Region, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Saskatoon Health Region
University of Saskatchewan

Data source: University of Saskatchewan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saskatoon, Canada